- Home
- NXST vs BBIO Comparison
NXST vs BBIO Comparison
Compare NXST & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXST
- BBIO
- Stock Information
- Founded
- NXST 1996
- BBIO 2015
- Country
- NXST United States
- BBIO United States
- Employees
- NXST N/A
- BBIO N/A
- Industry
- NXST Broadcasting
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- NXST Industrials
- BBIO Health Care
- Exchange
- NXST Nasdaq
- BBIO Nasdaq
- Market Cap
- NXST 5.7B
- BBIO 4.9B
- IPO Year
- NXST 2003
- BBIO 2019
- Fundamental
- Price
- NXST $166.18
- BBIO $24.92
- Analyst Decision
- NXST Strong Buy
- BBIO Strong Buy
- Analyst Count
- NXST 7
- BBIO 13
- Target Price
- NXST $199.71
- BBIO $46.83
- AVG Volume (30 Days)
- NXST 369.3K
- BBIO 1.4M
- Earning Date
- NXST 11-07-2024
- BBIO 11-12-2024
- Dividend Yield
- NXST 4.08%
- BBIO N/A
- EPS Growth
- NXST 46.23
- BBIO N/A
- EPS
- NXST 17.25
- BBIO N/A
- Revenue
- NXST $5,224,000,000.00
- BBIO $217,765,000.00
- Revenue This Year
- NXST $14.01
- BBIO $3,690.39
- Revenue Next Year
- NXST N/A
- BBIO N/A
- P/E Ratio
- NXST $9.63
- BBIO N/A
- Revenue Growth
- NXST 2.11
- BBIO 2209.77
- 52 Week Low
- NXST $141.38
- BBIO $21.62
- 52 Week High
- NXST $191.86
- BBIO $44.32
- Technical
- Relative Strength Index (RSI)
- NXST 44.45
- BBIO 51.72
- Support Level
- NXST $163.92
- BBIO $24.09
- Resistance Level
- NXST $191.86
- BBIO $27.57
- Average True Range (ATR)
- NXST 6.31
- BBIO 1.30
- MACD
- NXST -1.44
- BBIO 0.08
- Stochastic Oscillator
- NXST 8.09
- BBIO 52.84
About NXST Nexstar Media Group Inc.
Nexstar Media Group Inc is the largest television station owner-operator in the United States with over 200 stations in 116 markets. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. The 2019 merger with Tribune made Nexstar the top broadcast affiliate for both Fox and CBS as well as the number-two partner for NBC and number three for ABC. The firm has stations in 12 of the top 20 television markets and reaches 68% of us TV households. Nexstar also owns NewsNation (formerly WGN), a nationwide pay-television network, 75% of The CW, and a 31% stake in Food Network and Cooking Channel.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, acoramidis (AG10), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.